These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 20695726

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Prostate-specific antigen vs prostate-specific antigen density as a predictor of upgrading in men diagnosed with Gleason 6 prostate cancer by contemporary multicore prostate biopsy.
    Oh JJ, Hong SK, Lee JK, Lee BK, Lee S, Kwon OS, Byun SS, Lee SE.
    BJU Int; 2012 Dec; 110(11 Pt B):E494-9. PubMed ID: 22540236
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Volume-adjusted prostate-specific antigen (PSA) variables in detecting impalpable prostate cancer in men with PSA levels of 2-4 ng/mL: transabdominal measurement makes a significant contribution.
    Kobayashi T, Kawahara T, Nishizawa K, Ogura K, Mitsumori K, Ide Y.
    BJU Int; 2005 Jun; 95(9):1245-8. PubMed ID: 15892809
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Peripheral zone PSA density: a predominant variable to improve prostate cancer detection efficiency in men with PSA higher than 4 ng ml-1.
    Wang C, Wang YY, Wang SY, Ding JX, Ding M, Ruan Y, Wang XH, Jing YF, Han BM, Xia SJ, Jiang CY, Zhao FJ.
    Asian J Androl; 2021 Jun; 23(4):415-420. PubMed ID: 33473011
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A higher PSA-density cut-off level in patients with intermediate PSA values for the early detection of prostate cancer.
    Mochtar CA, Rahardjo D, Umbas R.
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():514-22. PubMed ID: 10895203
    [Abstract] [Full Text] [Related]

  • 37. Inverse association between histologic inflammation in needle biopsy specimens and prostate cancer in men with serum PSA of 10-50 ng/mL.
    Terakawa T, Miyake H, Kanomata N, Kumano M, Takenaka A, Fujisawao M.
    Urology; 2008 Dec; 72(6):1194-7. PubMed ID: 18829081
    [Abstract] [Full Text] [Related]

  • 38. Free PSA/total PSA ratio increases the detection rate of prostate cancer in twelve-core biopsy.
    Yokomizo Y, Miyoshi Y, Nakaigawa N, Makiyama K, Ogawa T, Yao M, Kubota Y, Uemura H.
    Urol Int; 2009 Dec; 82(3):280-5. PubMed ID: 19440014
    [Abstract] [Full Text] [Related]

  • 39. Role of PSA-related variables in improving positive ratio of biopsy of prostate cancer within serum PSA gray zone.
    Liu B, Pan TJ.
    Urologia; 2014 Dec; 81(3):173-6. PubMed ID: 24557815
    [Abstract] [Full Text] [Related]

  • 40. Prostate-specific antigen density: a means to enhance detection of prostate cancer.
    Ramon J, Boccon-Gibod L, Billebaud T, Astier L, Kobelinsky M, Meulemans A, Dauge MC, Boccon-Gibod L, Villers A.
    Eur Urol; 1994 Dec; 25(4):288-94; discussion 304. PubMed ID: 7519990
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.